Do analysts recommend AVNT or WLKP?

Avient currently has a consensus target price of $45.71, suggesting a potential upside of 21.42%. Given Avient's higher possible upside, equities analysts plainly believe Avient is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avient 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts rate WLKP or CC?

Chemours has a consensus price target of $24.60, indicating a potential upside of 12.99%. Given Chemours' higher possible upside, analysts clearly believe Chemours is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Chemours 1 Sell rating(s) 5 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.42

Do analysts recommend WLKP or NGVT?

Ingevity has a consensus price target of $80.00, indicating a potential upside of 9.33%. Given Ingevity's higher probable upside, analysts plainly believe Ingevity is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Ingevity 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Do analysts prefer PCT or WLKP?

PureCycle Technologies presently has a consensus price target of $12.25, suggesting a potential upside of 40.80%. Given PureCycle Technologies' higher possible upside, equities analysts clearly believe PureCycle Technologies is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureCycle Technologies 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts recommend BAK or WLKP?

Braskem currently has a consensus price target of $3.40, indicating a potential upside of 15.84%. Given Braskem's higher possible upside, research analysts clearly believe Braskem is more favorable than Westlake Chemical Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Braskem 4 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.63 Westlake Chemical Partners 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Westlake Chemical Partners (WLKP) Competitors

$22.66 +0.06 (+0.24%)

Closing price 06/18/2026 03:58 PM Eastern

Extended Trading

$22.65 -0.01 (-0.02%)

As of 06/18/2026 04:10 PM Eastern

Compare

WLKP vs. AVNT, CC, NGVT, PCT, and BAK

Should you buy Westlake Chemical Partners stock or one of its competitors? MarketBeat compares Westlake Chemical Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Westlake Chemical Partners include Avient (AVNT), Chemours (CC), Ingevity (NGVT), PureCycle Technologies (PCT), and Braskem (BAK). These companies are all part of the "chemicals" industry.

How does Westlake Chemical Partners compare to Avient?

Avient (NYSE:AVNT) and Westlake Chemical Partners (NYSE:WLKP) are both basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

Avient has a net margin of 4.81% compared to Westlake Chemical Partners' net margin of 4.69%. Avient's return on equity of 11.11% beat Westlake Chemical Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	4.81%	11.11%	4.40%
Westlake Chemical Partners	4.69%	7.15%	4.57%

Avient has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market. Comparatively, Westlake Chemical Partners has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Avient currently has a consensus target price of $45.71, suggesting a potential upside of 21.42%. Given Avient's higher possible upside, equities analysts plainly believe Avient is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Avient has higher revenue and earnings than Westlake Chemical Partners. Westlake Chemical Partners is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.26B	1.06	$81.90M	$1.72	21.89
Westlake Chemical Partners	$1.17B	0.68	$48.70M	$1.64	13.81

Avient pays an annual dividend of $1.10 per share and has a dividend yield of 2.9%. Westlake Chemical Partners pays an annual dividend of $1.89 per share and has a dividend yield of 8.3%. Avient pays out 64.0% of its earnings in the form of a dividend. Westlake Chemical Partners pays out 115.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Avient has increased its dividend for 1 consecutive years.

In the previous week, Avient had 2 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 2 mentions for Avient and 0 mentions for Westlake Chemical Partners. Avient's average media sentiment score of 0.33 beat Westlake Chemical Partners' score of 0.00 indicating that Avient is being referred to more favorably in the media.

Company	Overall Sentiment
Avient	Neutral
Westlake Chemical Partners	Neutral

95.5% of Avient shares are owned by institutional investors. Comparatively, 78.3% of Westlake Chemical Partners shares are owned by institutional investors. 0.9% of Avient shares are owned by insiders. Comparatively, 1.1% of Westlake Chemical Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Avient beats Westlake Chemical Partners on 15 of the 19 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Chemours?

Westlake Chemical Partners (NYSE:WLKP) and Chemours (NYSE:CC) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Westlake Chemical Partners has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Westlake Chemical Partners	$1.17B	0.68	$48.70M	$1.64	13.81
Chemours	$5.81B	0.56	-$386M	-$2.64	N/A

In the previous week, Chemours had 2 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 2 mentions for Chemours and 0 mentions for Westlake Chemical Partners. Westlake Chemical Partners' average media sentiment score of 0.00 equaled Chemours'average media sentiment score.

Company	Overall Sentiment
Westlake Chemical Partners	Neutral
Chemours	Neutral

Westlake Chemical Partners pays an annual dividend of $1.89 per share and has a dividend yield of 8.3%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. Westlake Chemical Partners pays out 115.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out -13.3% of its earnings in the form of a dividend.

78.3% of Westlake Chemical Partners shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 1.1% of Westlake Chemical Partners shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Westlake Chemical Partners has a net margin of 4.69% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Westlake Chemical Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Westlake Chemical Partners	4.69%	7.15%	4.57%
Chemours	-6.82%	52.49%	1.78%

Chemours has a consensus price target of $24.60, indicating a potential upside of 12.99%. Given Chemours' higher possible upside, analysts clearly believe Chemours is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

Westlake Chemical Partners has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Chemours has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market.

Summary

Westlake Chemical Partners beats Chemours on 10 of the 17 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Ingevity?

Westlake Chemical Partners (NYSE:WLKP) and Ingevity (NYSE:NGVT) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

In the previous week, Ingevity had 5 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 5 mentions for Ingevity and 0 mentions for Westlake Chemical Partners. Ingevity's average media sentiment score of 1.15 beat Westlake Chemical Partners' score of 0.00 indicating that Ingevity is being referred to more favorably in the news media.

Company	Overall Sentiment
Westlake Chemical Partners	Neutral
Ingevity	Positive

Westlake Chemical Partners has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Ingevity has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

78.3% of Westlake Chemical Partners shares are owned by institutional investors. Comparatively, 91.6% of Ingevity shares are owned by institutional investors. 1.1% of Westlake Chemical Partners shares are owned by insiders. Comparatively, 0.9% of Ingevity shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Westlake Chemical Partners has higher earnings, but lower revenue than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Westlake Chemical Partners	$1.17B	0.68	$48.70M	$1.64	13.81
Ingevity	$1.17B	2.18	-$167.10M	-$3.55	N/A

Ingevity has a consensus price target of $80.00, indicating a potential upside of 9.33%. Given Ingevity's higher probable upside, analysts plainly believe Ingevity is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Westlake Chemical Partners has a net margin of 4.69% compared to Ingevity's net margin of -10.55%. Ingevity's return on equity of 207.82% beat Westlake Chemical Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Westlake Chemical Partners	4.69%	7.15%	4.57%
Ingevity	-10.55%	207.82%	9.70%

Summary

Ingevity beats Westlake Chemical Partners on 10 of the 16 factors compared between the two stocks.

How does Westlake Chemical Partners compare to PureCycle Technologies?

PureCycle Technologies (NASDAQ:PCT) and Westlake Chemical Partners (NYSE:WLKP) are both small-cap chemicals companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

PureCycle Technologies presently has a consensus price target of $12.25, suggesting a potential upside of 40.80%. Given PureCycle Technologies' higher possible upside, equities analysts clearly believe PureCycle Technologies is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PureCycle Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

PureCycle Technologies has a beta of 2.48, meaning that its stock price is 148% more volatile than the broader market. Comparatively, Westlake Chemical Partners has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Westlake Chemical Partners has higher revenue and earnings than PureCycle Technologies. PureCycle Technologies is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PureCycle Technologies	$10.90M	144.33	-$182.57M	-$1.47	N/A
Westlake Chemical Partners	$1.17B	0.68	$48.70M	$1.64	13.81

Westlake Chemical Partners has a net margin of 4.69% compared to PureCycle Technologies' net margin of -2,062.36%. Westlake Chemical Partners' return on equity of 7.15% beat PureCycle Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PureCycle Technologies	-2,062.36%	-393.01%	-22.56%
Westlake Chemical Partners	4.69%	7.15%	4.57%

In the previous week, PureCycle Technologies had 9 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 9 mentions for PureCycle Technologies and 0 mentions for Westlake Chemical Partners. PureCycle Technologies' average media sentiment score of 0.67 beat Westlake Chemical Partners' score of 0.00 indicating that PureCycle Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
PureCycle Technologies	Positive
Westlake Chemical Partners	Neutral

63.0% of PureCycle Technologies shares are held by institutional investors. Comparatively, 78.3% of Westlake Chemical Partners shares are held by institutional investors. 18.8% of PureCycle Technologies shares are held by insiders. Comparatively, 1.1% of Westlake Chemical Partners shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Westlake Chemical Partners beats PureCycle Technologies on 8 of the 15 factors compared between the two stocks.

How does Westlake Chemical Partners compare to Braskem?

Braskem (NYSE:BAK) and Westlake Chemical Partners (NYSE:WLKP) are both small-cap chemicals companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

Braskem currently has a consensus price target of $3.40, indicating a potential upside of 15.84%. Given Braskem's higher possible upside, research analysts clearly believe Braskem is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Braskem	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.63
Westlake Chemical Partners	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Westlake Chemical Partners has lower revenue, but higher earnings than Braskem. Braskem is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Braskem	$12.66B	0.09	-$1.77B	-$4.22	N/A
Westlake Chemical Partners	$1.17B	0.68	$48.70M	$1.64	13.81

In the previous week, Braskem had 4 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 4 mentions for Braskem and 0 mentions for Westlake Chemical Partners. Westlake Chemical Partners' average media sentiment score of 0.00 beat Braskem's score of -0.17 indicating that Westlake Chemical Partners is being referred to more favorably in the news media.

Company	Overall Sentiment
Braskem	Neutral
Westlake Chemical Partners	Neutral

78.3% of Westlake Chemical Partners shares are held by institutional investors. 0.0% of Braskem shares are held by company insiders. Comparatively, 1.1% of Westlake Chemical Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Braskem has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market. Comparatively, Westlake Chemical Partners has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Westlake Chemical Partners has a net margin of 4.69% compared to Braskem's net margin of -13.72%. Westlake Chemical Partners' return on equity of 7.15% beat Braskem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Braskem	-13.72%	-23.17%	2.72%
Westlake Chemical Partners	4.69%	7.15%	4.57%

Summary

Westlake Chemical Partners beats Braskem on 11 of the 15 factors compared between the two stocks.

Get Westlake Chemical Partners News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WLKP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WLKP vs. The Competition

Export

Metric	Westlake Chemical Partners	CHEM Industry	Materials Sector	NYSE Exchange
Market Cap	$796.56M	$15.63B	$4.76B	$23.20B
Dividend Yield	8.34%	1.93%	4.99%	4.06%
P/E Ratio	13.81	36.02	23.42	31.61
Price / Sales	0.68	2.56	6,006.78	111.85
Price / Cash	4.51	14.83	26.97	24.44
Price / Book	1.00	4.98	9.23	4.68
Net Income	$48.70M	$376.36M	$156.93M	$1.08B
7 Day Performance	-2.77%	-0.88%	0.29%	-0.82%
1 Month Performance	0.40%	3.20%	-2.04%	1.07%
1 Year Performance	3.33%	20.76%	57.17%	25.02%

Westlake Chemical Partners Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WLKP Westlake Chemical Partners	3.1258 of 5 stars	$22.66 +0.2%	N/A	+3.3%	$796.56M	$1.17B	13.81	150
AVNT Avient	4.4329 of 5 stars	$35.57 +3.1%	$45.71 +28.5%	+12.6%	$3.26B	$3.26B	20.68	9,000	Gap Down
CC Chemours	3.2109 of 5 stars	$20.21 -3.1%	$24.60 +21.8%	+102.5%	$3.04B	$5.81B	N/A	5,700	News Coverage Negative News
NGVT Ingevity	2.5369 of 5 stars	$69.26 +3.5%	$80.00 +15.5%	+77.0%	$2.41B	$1.17B	N/A	1,500	News Coverage Positive News Analyst Upgrade
PCT PureCycle Technologies	2.7059 of 5 stars	$10.80 -10.1%	$12.00 +11.1%	-33.2%	$1.95B	$8.35M	N/A	120	Analyst Forecast Analyst Revision Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WLKP) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Westlake Chemical Partners (WLKP) Competitors

WLKP vs. AVNT, CC, NGVT, PCT, and BAK

How does Westlake Chemical Partners compare to Avient?

Summary

How does Westlake Chemical Partners compare to Chemours?

Summary

How does Westlake Chemical Partners compare to Ingevity?

Summary

How does Westlake Chemical Partners compare to PureCycle Technologies?

Summary

How does Westlake Chemical Partners compare to Braskem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WLKP vs. The Competition

Westlake Chemical Partners Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Westlake Chemical Partners (WLKP) Competitors

WLKP vs. AVNT, CC, NGVT, PCT, and BAK

How does Westlake Chemical Partners compare to Avient?

Is AVNT or WLKP more profitable?

Which has more risk and volatility, AVNT or WLKP?

Do analysts recommend AVNT or WLKP?

Which has stronger valuation and earnings, AVNT or WLKP?

Is AVNT or WLKP a better dividend stock?

Does the media favor AVNT or WLKP?

Do institutionals & insiders have more ownership in AVNT or WLKP?

Summary

How does Westlake Chemical Partners compare to Chemours?

Which has stronger valuation & earnings, WLKP or CC?

Does the media refer more to WLKP or CC?

Is WLKP or CC a better dividend stock?

Do institutionals and insiders hold more shares of WLKP or CC?

Is WLKP or CC more profitable?

Do analysts rate WLKP or CC?

Which has more risk & volatility, WLKP or CC?

Summary

How does Westlake Chemical Partners compare to Ingevity?

Does the media favor WLKP or NGVT?

Which has more volatility and risk, WLKP or NGVT?

Do insiders and institutionals believe in WLKP or NGVT?

Which has preferable earnings & valuation, WLKP or NGVT?

Do analysts recommend WLKP or NGVT?

Is WLKP or NGVT more profitable?

Summary

How does Westlake Chemical Partners compare to PureCycle Technologies?

Do analysts prefer PCT or WLKP?

Which has more volatility & risk, PCT or WLKP?

Which has stronger earnings & valuation, PCT or WLKP?

Is PCT or WLKP more profitable?

Does the media favor PCT or WLKP?

Do insiders and institutionals have more ownership in PCT or WLKP?

Summary

How does Westlake Chemical Partners compare to Braskem?

Do analysts recommend BAK or WLKP?

Which has preferable valuation & earnings, BAK or WLKP?

Does the media favor BAK or WLKP?

Do insiders & institutionals have more ownership in BAK or WLKP?

Which has more volatility & risk, BAK or WLKP?

Is BAK or WLKP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WLKP vs. The Competition

Westlake Chemical Partners Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools